Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.32
Delayed Data
As of Jan 13
 +0.0114 / +0.49%
Today’s Change
2.21
Today|||52-Week Range
4.80
+0.93%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.31
Today’s open2.31
Day’s range2.28 - 2.38
Volume20,072
Average volume (3 months)51,808
Market cap$25.7M
Dividend yield--
Data as of 3:59pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+47.37%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.67%
P/E ratioNM
Price/Sales1.80
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc-0.10-3.51%
PTXPernix Therapeutics ...+0.03+1.09%
MRNSMarinus Pharmaceutic...-0.18-12.86%
TKAITokai Pharmaceutical...0.000.00%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$21.0M
Annual profit (last year)-$9.2M
Net profit margin-44.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs